Endeavor Orthopaedics is an IP-protected platform technology company focused on the treatment of avulsion fractures through the integration of fracture repair with soft tissue management in one sterile implant. Our first FDA-cleared product, the Summit Patella Plating System, has already been used in more than 180 surgeries, where we are seeing a reoperation rate of less than 5%—a dramatic improvement compared to the industry standard of around 50% for patella fractures. Building on this success, we have 5 additional products in the pipeline designed to address avulsion fractures throughout the body, which will expand our addressable market from $225M to over $2B.